They used synthetic human and bovine PTH peptides to trigger the generation of antibodies in a patient with parathyroid carcinoma and metastases, severe bone disease, extreme hypercalcemia, and resistance to conventional treatment. The gene discussed is PTH; the disease is Hypercalcemia.